lansoprazole

Disclaimer to the Online Edition

This Manual has been designed for use in the NICU at London Health Sciences Centre (LHSC), London, Ontario, Canada, and represents clinical practice at this institution. The information contained within the Manual may not be applicable to other centres. If users of this Manual are not familiar with a drug, it is recommended that the official monograph be consulted before it is prescribed and administered. Any user of this information is advised that the contributors, Editor and LHSC are not responsible for any errors or omissions, and / or any consequences arising from the use of the information in this Manual.

lansoprazole

Indication

  • Proton pump inhibitor used in the treatment of reflux esophagitis

Dosage Guidelines

  • 0.5-1.5 mg/kg/dose ORAL once daily

Administration

  • ORAL
  • Administer prior to feeds

Adverse Effects

  • Abdominal pain, diarrhea, nausea
  • Elevations in AST, ALT, ALP (rare)

Comments

  • May decrease absorption of iron salts
  • Maximum effect: 1 to 4 weeks

Supplied As

  • 3 mg/mL oral suspension

References

LexiComp Pediatric and Neonatal